Brief: AOTI Reports Study In 3,126 Patients Shows Superior Durable Healing With TWO2 Therapy
27/04/2026 07:22
April 27 (Reuters) - Aoti Inc AOTI.L: AOTI INC - STUDY IN 3,126 PATIENTS SHOWS SUPERIOR DURABLE HEALING WITH TWO2 THERAPY AOTI INC - STUDY SHOWS 64.8% COMPLETE HEALING RATE, 2.7% RECURRENCE IN CHRONIC LOWER EXTREMITY WOUNDS AOTI INC - RETREATMENT DUE TO WOUND RECURRENCE 2.7% OVER 13.9 MONTHS FOLLOW-UP AOTI INC - TWO2 THERAPY REDUCES HOSPITALISATION RATE TO 3.7% AND AMPUTATION RATE TO 6.1% Source text: ID:nRSa9951Ba Further company coverage: AOTI.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aoti
See all newsBrief: AOTI Reports Study In 3,126 Patients Shows Superior Durable Healing With TWO2 Therapy
Aoti, Inc.: Grant of awards under Long Term Incentive Plan
Aoti, Inc.: 2025 Annual Report and Notice of AGM
Aoti, Inc.: Director/PDMR Shareholding
Brief: AOTI Expects Revenue Growth In FY 2026 To Be In Low Single Digits Compared To FY 2025